Cyfuse Biomedical K.K. Revenue

In the year 2025, Cyfuse Biomedical K.K. had annual revenue of 230.00M JPY with 325.93% growth. Cyfuse Biomedical K.K. had revenue of 169.00M in the quarter ending December 31, 2025, with 503.57% growth.

Revenue

230.00M

Revenue Growth

+325.93%

P/S Ratio

26.90

Revenue / Employee

10.95M

Employees

Market Cap

6.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	230.00M	176.00M	325.93%
Dec 31, 2024	54.00M	-7.00M	-11.48%
Dec 31, 2023	61.00M	-313.00M	-83.69%
Dec 31, 2022	374.00M	-334.00M	-47.18%
Dec 31, 2021	708.00M	571.00M	416.79%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
MedRx	128.00M
Nippon Chemiphar	32.52B
WDB coco	4.98B
SymBio Pharmaceuticals	1.31B
Solasia Pharma K.K.	429.00M
Morishita Jintan	12.87B
Wakamoto Pharmaceutical	9.43B
Taiko Pharmaceutical	6.40B

Revenue Rankings